Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Provide Mixed Ratings and Price Targets for Pactiv Evergreen

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finances (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, Goldman Sachs analyst Adam Samuelson reiterated a Neutral rating on Pactiv Evergreen (NASDAQ: PTVE) and raised the price target to $14, up from $12.5. This adjustment marks a series of updates that have seen the price target climb from $11 to $12.5 previously.

Other analysts have also weighed in on PTVE, offering a range of price targets. The average among them is $16.58, with the highest forecast coming in at $19.00. Baird analyst Ghansham Panjabi has similarly maintained a Neutral rating on PTVE, but has upped the price target to $12.

[bs_slider_forecast ticker=”PTVE”]

PTVE Stock Price Plummets by 10%: What Investors Need to Know

On March 4, 2024, PTVE stock experienced a significant drop in price, closing at $13.26, a decrease of $1.49 or 10.10% from the previous market close. Furthermore, in pre-market trading, the stock dropped an additional $0.25.

Investors who were holding PTVE shares may have been taken aback by this sudden drop in price. It is important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and investor sentiment. In this case, it appears that something may have caused investors to sell off their PTVE shares, leading to the sharp decline in price.

For investors considering buying or selling PTVE stock, it is essential to conduct thorough research and analysis to understand the reasons behind the price drop and determine whether it is a temporary dip or a sign of more significant issues with the company. Keeping an eye on market trends and news related to PTVE can help investors make informed decisions about their investments.

Currently Playing

PTVE Stock Reports Mixed Performance in Financial Results for 2024: Revenue and Net Income Decrease

On March 4, 2024, PTVE stock experienced a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, PTVE’s total revenue for the year was $5.51 billion, which represented a decrease of 11.41% compared to the previous year. The total revenue for the fourth quarter was $1.27 billion, which remained flat compared to the previous quarter. PTVE reported a loss of $223.00 million for the year, which was a significant decrease of 170.13% compared to the previous year. The net income for the fourth quarter was $21.00 million, which also decreased by 22.22% compared to the previous quarter. Earnings per share (EPS) for PTVE were reported at -$1.26 for the year, representing a decrease of 171.4% compared to the previous year. The EPS for the fourth quarter was $0.11, which remained flat compared to the previous quarter. Overall, PTVE’s financial performance on March 4, 2024, showed a decrease in total revenue and net income compared to the previous year. However, the company was able to maintain its total revenue and net income at the same level compared to the previous quarter. The decrease in EPS for the year was significant, but the EPS for the fourth quarter remained stable. Investors and analysts will likely closely monitor PTVE’s future financial performance to assess the company’s ability to rebound from the recent declines and drive growth in the coming quarters. It will be crucial for PTVE to implement strategic measures to improve its financial metrics and regain investor confidence in the stock.

[stock_market_chart symbol=”PTVE” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: PTVE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

Finance_ projections

Financial Analysts Bullish on Li Auto Stock

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

Recommended

Biotechnology Market Capitalization

BioAffinity Technologies Resumes Trading on Stock Market What Investors Need to Know

2 years ago
Broadridge Stock

Broadridge Financial: Strategic Positioning Drives Market Leadership

7 days ago
TMUS stock news

MeridianLink NYSE MLNK Reports Q4 2023 Earnings Below Analyst Predictions Optimistic for 2024

2 years ago
Absence_on_WalmartOne

Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism

Marsh McLennan Appoints New Leader to Drive International Expansion Strategy

Polestar Faces Mounting Challenges as Recall Compounds Financial Woes

Kratos Defense Secures Coveted Spot in S&P MidCap 400 Index

American Express Doubles Down on Premium Market Strategy

Snowflake Gains Momentum with Leadership Shift and Strategic Alliances

Trending

Dentsply Sirona Stock
Earnings

Dentsply Sirona’s Rocky Road to Recovery

by Dieter Jaworski
September 22, 2025
0

Dentsply Sirona, a leading manufacturer of dental products and technologies, finds itself navigating a period of significant...

VanEck Video Gaming and eSports ETF Stock

A Closer Look at the VanEck Gaming ETF: A Resilient Tech Niche

September 22, 2025
Roku Stock

Roku Stock: Strong Fundamentals Clash with Institutional Selling

September 22, 2025
Anavex Stock

Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism

September 22, 2025
Marsh McLennan Stock

Marsh McLennan Appoints New Leader to Drive International Expansion Strategy

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dentsply Sirona’s Rocky Road to Recovery
  • A Closer Look at the VanEck Gaming ETF: A Resilient Tech Niche
  • Roku Stock: Strong Fundamentals Clash with Institutional Selling

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com